Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2641

1.

The Role of Novel Approaches and New Findings in the Pharmacology of Tuberculosis Medicines in Improving Treatment Outcomes.

Falzon D, Jaramillo E, Gilpin C, Weyer K.

Clin Infect Dis. 2018 Nov 28;67(suppl_3):S365-S367. doi: 10.1093/cid/ciy710. No abstract available.

2.

The Differences in Antibiotic Decision-making Between Acute Surgical and Acute Medical Teams: An Ethnographic Study of Culture and Team Dynamics.

Charani E, Ahmad R, Rawson TM, Castro-Sanchèz E, Tarrant C, Holmes AH.

Clin Infect Dis. 2018 Nov 15. doi: 10.1093/cid/ciy844. [Epub ahead of print]

3.

The Importance of Heterogeneity to the Epidemiology of Tuberculosis.

Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RM, McBryde ES, Melsew YA, Menzies NA, Arinaminpathy N, Shrestha S, Dowdy DW.

Clin Infect Dis. 2018 Nov 1. doi: 10.1093/cid/ciy938. [Epub ahead of print]

4.

Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.

Altamirano J, Purington N, Behl R, Sarnquist C, Holubar M, García-García L, Ferreyra-Reyes L, Montero-Campos R, Cruz-Hervert LP, Boyle S, Modlin J, van Hoorebeke C, Leary S, Huang C, Sommer M, Ferreira-Guerrero E, Delgado-Sanchez G, Canizales-Quintero S, Díaz Ortega JL, Desai M, Maldonado YA.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S4-S17. doi: 10.1093/cid/ciy650.

5.

Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame.

Gaensbauer JT, Gast C, Bandyopadhyay AS, O'Ryan M, Saez-Llorens X, Rivera L, Lopez-Medina E, Melgar M, Weldon WC, Oberste MS, Rüttimann R, Clemens R, Asturias EJ.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S57-S65. doi: 10.1093/cid/ciy649.

6.

A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus.

Matrajt G, Naughton B, Bandyopadhyay AS, Meschke JS.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S90-S97. doi: 10.1093/cid/ciy638.

7.

Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.

Altamirano J, Leary S, van Hoorebeke C, Sarnquist C, Behl R, García-García L, Ferreyra-Reyes L, Huang C, Sommer M, Maldonado Y.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S98-S102. doi: 10.1093/cid/ciy639.

8.

Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples.

van Hoorebeke C, Huang C, Leary S, Holubar M, Altamirano J, Halpern MS, Sommer M, Maldonado Y.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S121-S126. doi: 10.1093/cid/ciy648.

9.

Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses.

Bhaumik SK, Kulkarni RR, Weldon WC, Silveira ELV, Ahmed H, Gunisetty S, Chandele A, Antia R, Verma H, Sutter R, Pallansch MA, Oberste MS, Villinger F, Orenstein W, Murali-Krishna K.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S66-S77. doi: 10.1093/cid/ciy634.

10.

Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.

Jarvis CI, Altamirano J, Sarnquist C, Edmunds WJ, Maldonado Y.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S18-S25. doi: 10.1093/cid/ciy622.

11.

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?

Resik S, Tejeda A, Mach O, Fonseca M, Diaz M, Alemany N, Heng Hung L, Aleman Y, Mesa I, Garcia G, Sutter RW.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S51-S56. doi: 10.1093/cid/ciy604.

12.

Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings.

Fu R, Altamirano J, Sarnquist CC, Maldonado YA, Andrews JR.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S26-S34. doi: 10.1093/cid/ciy605.

13.

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine-only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants.

Brickley EB, Wieland-Alter W, Connor RI, Ackerman ME, Boesch AW, Arita M, Weldon WC, O'Ryan MG, Bandyopadhyay AS, Wright PF.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S42-S50. doi: 10.1093/cid/ciy603.

14.

OPV Vaccination and Shedding Patterns in Mexican and US Children.

Altamirano J, Sarnquist C, Behl R, García-García L, Ferreyra-Reyes L, Leary S, Maldonado Y.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S85-S89. doi: 10.1093/cid/ciy636.

15.

Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.

Sarnquist C, Holubar M, García-García L, Ferreyra-Reyes L, Delgado-Sánchez G, Cruz-Hervert LP, Montero-Campos R, Altamirano J, Purington N, Boyle S, Modlin J, Ferreira-Guerrero E, Canizales-Quintero S, Díaz Ortega JL, Desai M, Maldonado YA.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S115-S120. doi: 10.1093/cid/ciy606.

16.

Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.

Halpern MS, Altamirano J, Maldonado Y.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S78-S84. doi: 10.1093/cid/ciy635.

17.

Seroprevalence of Poliomyelitis Antibodies Among Children Aged 1 to 4 Years Old and Factors Associated With Poliovirus Susceptibility; Mexican Health and Nutrition Survey, 2012.

Díaz-Quiñónez JA, Díaz-Ortega JL, Cruz-Hervert P, Ferreira-Guerrero E, Delgado-Sánchez G, Ferreyra-Reyes L, López-Martínez I, Torres-Longoria B, Aparicio-Antonio R, Montero-Campos R, Mongua-Rodríguez N, Garcia-Garcia L.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S110-S114. doi: 10.1093/cid/ciy621.

18.

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.

Bandyopadhyay AS, Modlin JF, Wenger J, Gast C.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S35-S41. doi: 10.1093/cid/ciy633.

19.

Plasma biomarkers to detect prevalent, or predict progressive, HIV-1-associated tuberculosis.

Lesosky M, Rangaka MX, Pienaar C, Coussens AK, Goliath R, Mathee S, Mwansa-Kambafwile J, Maartens G, Wilkinson RJ, Wilkinson KA.

Clin Infect Dis. 2018 Sep 26. doi: 10.1093/cid/ciy823. [Epub ahead of print]

20.

The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.

Gibani MM, Voysey M, Jin C, Jones C, Thomaides-Brears H, Jones E, Baker P, Morgan M, Simmons A, Gordon MA, Cerundolo V, Pitzer VE, Angus B, Levine MM, Darton TC, Pollard AJ.

Clin Infect Dis. 2018 Sep 25. doi: 10.1093/cid/ciy670. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center